1. Home
  2. KOPN vs RZLT Comparison

KOPN vs RZLT Comparison

Compare KOPN & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kopin Corporation

KOPN

Kopin Corporation

HOLD

Current Price

$5.22

Market Cap

396.8M

Sector

Technology

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$4.33

Market Cap

321.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOPN
RZLT
Founded
1984
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
396.8M
321.6M
IPO Year
2025
2011

Fundamental Metrics

Financial Performance
Metric
KOPN
RZLT
Price
$5.22
$4.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$4.69
$9.67
AVG Volume (30 Days)
7.8M
1.8M
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
103.03
26.32
EPS
N/A
N/A
Revenue
$1,530,311.00
N/A
Revenue This Year
$50.07
N/A
Revenue Next Year
$33.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
46.53
N/A
52 Week Low
$1.44
$1.07
52 Week High
$6.61
$11.46

Technical Indicators

Market Signals
Indicator
KOPN
RZLT
Relative Strength Index (RSI) 51.68 65.78
Support Level $2.24 $2.91
Resistance Level $6.53 $4.71
Average True Range (ATR) 0.60 0.36
MACD -0.16 0.03
Stochastic Oscillator 31.95 78.88

Price Performance

Historical Comparison
KOPN
RZLT

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: